Dimensional Fund Advisors LP lifted its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,157,170 shares of the healthcare conglomerate’s stock after purchasing an additional 17,040 shares during the quarter. UnitedHealth Group makes up about 0.3% of Dimensional Fund Advisors LP’s holdings, making the stock its 25th biggest position. Dimensional Fund Advisors LP owned approximately 0.33% of UnitedHealth Group worth $839,896,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. FNY Investment Advisers LLC acquired a new position in UnitedHealth Group in the 3rd quarter valued at $106,000. Fort L.P. acquired a new position in UnitedHealth Group in the 2nd quarter valued at $119,000. Polaris Greystone Financial Group LLC acquired a new position in UnitedHealth Group in the 3rd quarter valued at $120,000. Columbia Asset Management acquired a new position in UnitedHealth Group in the 3rd quarter valued at $152,000. Finally, Pathstone Family Office LLC grew its stake in UnitedHealth Group by 1,430.8% in the 3rd quarter. Pathstone Family Office LLC now owns 597 shares of the healthcare conglomerate’s stock valued at $160,000 after buying an additional 558 shares during the last quarter. Institutional investors own 85.57% of the company’s stock.
UNH has been the topic of a number of research analyst reports. Morgan Stanley raised their target price on shares of UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a research note on Wednesday, September 5th. Citigroup lowered shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 target price on the stock. in a research note on Monday, September 10th. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 11th. Cowen initiated coverage on shares of UnitedHealth Group in a research note on Monday, September 17th. They issued an “outperform” rating and a $308.00 target price on the stock. Finally, Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 18th. Two equities research analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $292.48.
In other UnitedHealth Group news, Director Richard T. Burke sold 20,000 shares of the stock in a transaction on Wednesday, September 12th. The shares were sold at an average price of $263.41, for a total value of $5,268,200.00. Following the completion of the sale, the director now directly owns 1,720,112 shares of the company’s stock, valued at approximately $453,094,701.92. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Kenneth Irwin Shine sold 163 shares of the stock in a transaction on Friday, November 9th. The shares were sold at an average price of $274.83, for a total transaction of $44,797.29. The disclosure for this sale can be found here. Over the last three months, insiders sold 34,395 shares of company stock valued at $9,186,302. Insiders own 0.87% of the company’s stock.
Shares of UnitedHealth Group stock opened at $269.18 on Friday. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.61. UnitedHealth Group Inc has a fifty-two week low of $208.48 and a fifty-two week high of $287.94. The firm has a market capitalization of $267.97 billion, a price-to-earnings ratio of 26.73, a P/E/G ratio of 1.60 and a beta of 0.76.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, beating analysts’ consensus estimates of $3.30 by $0.11. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The firm had revenue of $56.56 billion during the quarter, compared to the consensus estimate of $56.34 billion. During the same period in the prior year, the firm earned $2.66 EPS. The business’s revenue was up 12.4% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group Inc will post 12.82 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date of this dividend is Friday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.75%.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another site, it was copied illegally and reposted in violation of United States and international trademark and copyright laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2018/12/08/dimensional-fund-advisors-lp-grows-holdings-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: How to Calculate Compound Annual Growth Rate (CAGR)
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.